key: cord-0744211-xor91cnq
authors: Dicpinigaitis, Peter V.
title: Post-viral Anosmia (Loss of Sensation of Smell) Did Not Begin with COVID-19!
date: 2021-04-24
journal: Lung
DOI: 10.1007/s00408-021-00448-4
sha: da9b48381c93fda2b2989735eaaa00b034311600
doc_id: 744211
cord_uid: xor91cnq

nan

entity with the most robust support is olfactory training [10, 11] as pharmacological therapies have not been properly investigated in clinical trials [12] .

Olfactory training involves patients with olfactory dysfunction inhaling a series of four odorants twice daily, for approximately 10 s each, over a 12-week period [13] . The four chemicals (odors) employed are phenyl ethyl alcohol [PEA] (rose), eucalyptol (eucalyptus), citronellal (lemon), and eugenol (cloves) [13] . Although proven successful, the mechanism(s) by which olfactory training improves the sensation of smell remain incompletely understood. Functional brain MRI (fMRI) studies of anosmic subjects with PVOD undergoing olfactory training over a 12-week period demonstrated that improvement in olfactory sensation was associated with modifications of functional connections within the olfactory, somatosensory, and integrative networks, which are involved in the processing of chemosensory input [14] . A recent study has shed further light on the apparently unique and dynamic neuroplasticity of the olfactory system [15] . Evaluation of resting-state fMRI imaging before and after 12 weeks of olfactory training revealed that PVOD subjects had increased connectivity within the visual cortex compared with control subjects, which decreased after olfactory training. In addition, four other network connectivity changes were noted after completion of olfactory training [15] .

Prompt and significant attention has been granted to PVOD since the onset of COVID-19 and its associated olfactory symptoms [16] . The pathophysiological mechanisms of SARS-CoV-2-associated olfactory dysfunction appear to be identical to those of PVOD [17] . Some guidance regarding the treatment of PVOD due to SARS-CoV-2 has already appeared. A small prospective study demonstrated benefit from a short course of oral corticosteroids in addition to olfactory training, but not from olfactory training alone [18] . The British Rhinological Society expert panel has published consensus guidelines on the management of new onset loss of smell with COVID-19 [19] . In this document, olfactory training was recommended for all patients with persistent loss of smell of more than 2 weeks' duration, and oral steroids, steroid rinses, and omega 3 supplements were recommended to be considered on an individual basis [19] .

Although PVOD was a well-established entity prior to COVID-19, guidance on optimal treatment strategies was lacking due to an absence of properly performed clinical trials. As the mechanisms of PVOD and COVID-19-associated olfactory dysfunction are likely to be similar or identical [17] , perhaps the current pandemic will facilitate the first-ever randomized, controlled trials that will, hopefully, inform management of both SARS-CoV-2-related and unrelated PVOD. Furthermore, an opportunity arises for physicians outside of the field of otorhinolaryngology to familiarize themselves with PVOD and with the concept of olfactory training which, as noted above, is considered first-line management for this disorder.

Conflict of interest Peter V. Dicpinigaitis, MD, is the Editor-in-Chief of LUNG.

Ultrastructural histopathology of human olfactory dysfunction

Postviral olfactory loss

Olfactory disorders following upper respiratory tract infections

Identification of viruses in patients with postviral olfactory dysfunction

Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients

Prognosis of postviral olfactory loss: follow-up study for longer than one year

Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction

Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations

Clinical practice guidelines for the management of olfactory dysfunction-secondary publication

Olfactory training for postviral olfactory dysfuncion: systematic review and meta-analysis

Effects of olfactory training in patients with postinfectious olfactory dysfunction

Pharmacologic treatment for postviral olfactory dysfunction: a systematic review

Effects of olfactory training in patients with olfactory loss

Olfactory training induces changes in regional functional connectivity in patients with long-term smell loss

Association of olfactory training with neural connectivity in adults with postviral olfactory dysfunction

A primer on viralassociated olfactory loss in the era of COVID-19

Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

Management of new onset loss of sense of smell during the COVID-19 pandemic-BRS consensus guidelines